Ad26.COV2-S/elasomeran/tozinameranMyocarditis: 7 case reports

被引：0

|

作者：

机构：

来源：

Reactions Weekly | 2022年 / 1903卷 / 1期

关键词：

D O I：

10.1007/s40278-022-13582-z

中图分类号：

学科分类号：

摘要：

引用

收藏

页码：20 / 20

相关论文

共 50 条

[21] Ad26.cov2-s/elasomeranLack of efficacy:2 case reports
Reactions Weekly, 2023, 1942 (1) : 17 - 17
[22] Ad26.COV2-S/elasomeran/tozinameranSplanchnic vein thrombosis and thrombosis at multiple unusual sites: 3 case reports
Reactions Weekly, 2022, 1910 (1) : 15 - 15
[23] Ad26.cov2-s/tozinameranTransient tachycardia and pseudoseizure: 2 case reports
Reactions Weekly, 2023, 1948 (1) : 20 - 20
[24] Ad26.cov2-s/elasomeran/immune globulin/tozinameranGuillain-Barre syndrome and lack of efficacy: 10 case reports
Reactions Weekly, 2023, 1952 (1) : 26 - 26
[25] Elasomeran/tozinameranMyocarditis: 2 case reports
Reactions Weekly, 2022, 1898 (1) : 179 - 179
[26] Elasomeran/tozinameranMyocarditis: 2 case reports
Reactions Weekly, 2022, 1899 (1) : 178 - 178
[27] Ad26.CoV2-S/elasomeranThrombosis with thrombocytopenia syndrome: 6 case reports
Reactions Weekly, 2022, 1909 (1) : 20 - 20
[28] Ad26.COV2-S/elasomeranAcute myocardial infarction and myocarditis: 2 case reports
Reactions Weekly, 2023, 1986 (1) : 19 - 19
[29] Ad26.COV2-S/tozinameranDe novo immune thrombocytopenia: 2 case reports
Reactions Weekly, 2022, 1919 (1) : 21 - 21
[30] Ad26.COV2-S/elasomeran/tozinameranAcute kidney injury, injection-site pain and nephrotic syndrome: 6 case reports
Reactions Weekly, 2023, 1963 (1) : 19 - 19

← 1 2 3 4 5 →